These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28289013)
21. Adrenaline auto-injector prescribing may be putting patients at risk. Baily D Br J Gen Pract; 2017 Oct; 67(663):444. PubMed ID: 28963404 [No Abstract] [Full Text] [Related]
22. [Indication for adrenalin autoinjector after anaphylaxis]. Malling HJ; Hansen KS; Mosbech H Ugeskr Laeger; 2012 Jun; 174(25):1741-3. PubMed ID: 22713223 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood. Turgay Yagmur I; Yilmaz Topal O; Kulhas Celik I; Toyran M; Civelek E; Dibek Misirlioglu E Allergy Asthma Proc; 2021 May; 42(3):e96-e100. PubMed ID: 33980345 [No Abstract] [Full Text] [Related]
24. [Pain estimation caused by adrenaline injectors for the treatment of anaphylaxis. The recommendation to practice the use prior to acute allergic reaction is supported by a cross-sectional study]. Zara K; Hellman BM; Zetterström O Lakartidningen; 2008 May 7-13; 105(19):1388-90. PubMed ID: 18574977 [No Abstract] [Full Text] [Related]
25. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea. Cho H; Kwon JW Korean J Intern Med; 2019 May; 34(3):643-650. PubMed ID: 30360025 [TBL] [Abstract][Full Text] [Related]
27. [Rapid and safe use of adrenaline auto-injectors: We have a problem!]. García-Magán C; Giráldez Montero JM; Moure-González JD; Rodríguez-Núñez A An Pediatr (Engl Ed); 2020 Jun; 92(6):388-389. PubMed ID: 31864845 [No Abstract] [Full Text] [Related]
28. Surveillance of the use of adrenaline auto-injectors in Japanese children. Ito K; Ono M; Kando N; Matsui T; Nakagawa T; Sugiura S; Ebisawa M Allergol Int; 2018 Apr; 67(2):195-200. PubMed ID: 28784272 [TBL] [Abstract][Full Text] [Related]
30. Adherence to the guidelines for adrenaline auto-injector prescription should be improved. Pouessel G; Beaudouin E; Renaudin JM; Moneret-Vautrin AM; Deschildre A; Pediatr Allergy Immunol; 2016 Jun; 27(4):430-3. PubMed ID: 26845628 [No Abstract] [Full Text] [Related]
31. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients. Ridolo E; Montagni M; Bonzano L; Savi E; Peveri S; Costantino MT; Crivellaro M; Manzotti G; Lombardi C; Caminati M; Incorvaia C; Senna G Intern Emerg Med; 2015 Dec; 10(8):937-41. PubMed ID: 25990486 [TBL] [Abstract][Full Text] [Related]
33. Use of epinephrine in emergency department depends on anaphylaxis severity in children. Dubus JC; Lê MS; Vitte J; Minodier P; Boutin A; Carsin A; Viudes G; Noel G Eur J Pediatr; 2019 Jan; 178(1):69-75. PubMed ID: 30269250 [TBL] [Abstract][Full Text] [Related]
34. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK. Gallagher M; Worth A; Cunningham-Burley S; Sheikh A Clin Exp Allergy; 2011 Jun; 41(6):869-77. PubMed ID: 21481022 [TBL] [Abstract][Full Text] [Related]
35. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department. Mostmans Y; Grosber M; Blykers M; Mols P; Naeije N; Gutermuth J Allergy; 2017 Mar; 72(3):492-497. PubMed ID: 27709624 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive hospital-based regional survey of anaphylaxis in Japanese children: Time trends of triggers and adrenaline use. Kitamura K; Ito T; Ito K Allergol Int; 2021 Oct; 70(4):452-457. PubMed ID: 34140240 [TBL] [Abstract][Full Text] [Related]
37. Identifying the factors and root causes associated with the unintentional usage of an adrenaline auto-injector in Japanese children and their caregivers. Sasaki K; Nakagawa T; Sugiura S; Ebisawa M; Ito K Allergol Int; 2018 Oct; 67(4):475-480. PubMed ID: 29519764 [TBL] [Abstract][Full Text] [Related]
38. Management and treatment of anaphylaxis in children: still too low the rate of prescription and administration of intramuscular epinephrine. Calamelli E; Mattana F; Cipriani F; Ricci G Int J Immunopathol Pharmacol; 2014; 27(4):597-605. PubMed ID: 25572739 [TBL] [Abstract][Full Text] [Related]
39. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Simons E; Sicherer SH; Simons FE Ann Allergy Asthma Immunol; 2012 May; 108(5):321-5. PubMed ID: 22541402 [TBL] [Abstract][Full Text] [Related]
40. Analysis of adrenaline autoinjectors acquisition in Portugal over 15 years. Fernandes M; Lourenço T; Spínola Santos A; Pereira Barbosa M Eur Ann Allergy Clin Immunol; 2023 Jan; 55(1):29-34. PubMed ID: 33949175 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]